首页> 外国专利> (1H-AZOL-1-YLMETHYL)SUBSTITUTED QUINOLINE,QUINAZOLINE OR QUINOXALINE DERIVATIVES,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

(1H-AZOL-1-YLMETHYL)SUBSTITUTED QUINOLINE,QUINAZOLINE OR QUINOXALINE DERIVATIVES,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

机译:(1H-氮杂-1-基)取代的喹啉,喹喔啉或喹喔啉衍生物,其制备和组成它们的药物成分

摘要

Novel (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives of formula CHEM the pharmaceutical acceptable acid addition salts thereof and the stereochemically isomeric forms thereof, wherein -X1=X2- is -CH=CH-, -CH=N-, or -N=CH-; R is hydrogen or C1-6alkyl; Y is hydrogen, C1-10alkyl, C3-7cycloalkyl, Ar1, Ar2-C1-6alkyl, C2-6alkenyl or C2-6alkynyl; Z is a radical of formula CHEM CHEM which compounds are useful for treating disorders which are characterized by an excessive proliferation and/or abnormal differentiation of epithelial tissues: pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
机译:的新的(1H-氮杂-1-基甲基)取代的喹啉,喹唑啉或喹喔啉衍生物或其药学上可接受的酸加成盐及其立体化学异构体形式,其中-X 1 = X 2-为- CH = CH-,-CH = N-或-N = CH-; R为氢或C 1-6烷基; Y是氢,C 1-10烷基,C 3-7环烷基,Ar 1,Ar 2 -C 1-6烷基,C 2-6烯基或C 2-6炔基; Z是式 的基团,该化合物可用于治疗特征在于上皮组织过度增殖和/或异常分化的疾病:包含此类化合物作为活性成分的药物组合物和制备所述化合物的方法和药物组合物。

著录项

  • 公开/公告号IL92486D0

    专利类型

  • 公开/公告日1990-08-31

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V.;

    申请/专利号IL19890092486

  • 发明设计人

    申请日1989-11-28

  • 分类号C07D;

  • 国家 IL

  • 入库时间 2022-08-22 06:18:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号